Theratechnologies (TSE:TH) Share Price Passes Above 50 Day Moving Average of $2.04

Shares of Theratechnologies Inc. (TSE:THGet Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$2.04 and traded as high as C$2.24. Theratechnologies shares last traded at C$2.23, with a volume of 55,925 shares traded.

Analyst Ratings Changes

Separately, Cantor Fitzgerald reissued an “overweight” rating on shares of Theratechnologies in a research note on Friday, January 12th.

Read Our Latest Stock Report on TH

Theratechnologies Trading Up 12.6 %

The stock has a market cap of C$102.54 million, a PE ratio of -1.81, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. The company has a debt-to-equity ratio of 562.07, a quick ratio of 0.64 and a current ratio of 1.34. The company’s 50-day moving average price is C$2.04 and its 200 day moving average price is C$2.20.

Theratechnologies (TSE:THGet Free Report) last released its quarterly earnings results on Wednesday, February 21st. The company reported C($0.11) EPS for the quarter. The firm had revenue of C$31.93 million for the quarter. Theratechnologies had a negative net margin of 29.30% and a negative return on equity of 1,116.86%. On average, sell-side analysts forecast that Theratechnologies Inc. will post 0.0305882 EPS for the current fiscal year.

About Theratechnologies

(Get Free Report)

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients.

Featured Articles

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.